BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3349458)

  • 1. In vitro antiproliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells.
    Noseda A; Berens ME; White JG; Modest EJ
    Cancer Res; 1988 Apr; 48(7):1788-91. PubMed ID: 3349458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
    Principe P; Sidoti C; Braquet P
    Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane peroxidative damage enhancement by the ether lipid class of antineoplastic agents.
    Wagner BA; Buettner GR; Burns CP
    Cancer Res; 1992 Nov; 52(21):6045-51. PubMed ID: 1394229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
    Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
    Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
    Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
    Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
    Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR; Bittman R; Peters A; Mayhew E
    J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC; Wykle RL; Modest EJ; Daniel LW
    Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.
    Fujiwara K; Modest EJ; Welander CE; Wallen CA
    Cancer Res; 1989 Nov; 49(22):6285-9. PubMed ID: 2804975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
    Hoffman DR; Hoffman LH; Snyder F
    Cancer Res; 1986 Nov; 46(11):5803-9. PubMed ID: 3756924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of ether-linked analogues of lysophosphatidate and their effect on the proliferation of human epithelial cancer cells in vitro.
    Ashagbley A; Samadder P; Bittman R; Erukulla RK; Byun HS; Arthur G
    Anticancer Res; 1996; 16(4A):1813-8. PubMed ID: 8712705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ether lipid 1-O-octadecyl-2-O-methoxy-rac-glycero-3-phosphocholine and its analogues platelet activating factor and carbamyl-platelet activating factor on the biosynthesis of interleukin-6 in human thymic epithelial cells cultivated in vitro.
    Cardile V; Mascarucci P; De Simoni MG; Jiang X; Bindoni M
    Cytokine; 1996 Sep; 8(9):698-701. PubMed ID: 8932980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids.
    Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P
    Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA; Buettner GR; Oberley LW; Burns CP
    Cancer Res; 1998 Jul; 58(13):2809-16. PubMed ID: 9661895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES; Kelley EE; Modest EJ; Burns CP
    Cancer Res; 1992 Nov; 52(22):6263-9. PubMed ID: 1423272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of anti-tumor ether lipids on ordered domains in model membranes.
    Heczková B; Slotte JP
    FEBS Lett; 2006 May; 580(10):2471-6. PubMed ID: 16638573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective induction of apoptosis in cancer cells by the ether lipid ET-18-OCH3 (Edelfosine): molecular structure requirements, cellular uptake, and protection by Bcl-2 and Bcl-X(L).
    Mollinedo F; Fernández-Luna JL; Gajate C; Martín-Martín B; Benito A; Martínez-Dalmau R; Modolell M
    Cancer Res; 1997 Apr; 57(7):1320-8. PubMed ID: 9102220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K; Modest EJ; Wallen CA
    Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships of antineoplastic ring-substituted ether phospholipid derivatives.
    Papazafiri P; Avlonitis N; Angelou P; Calogeropoulou T; Koufaki M; Scoulica E; Fragiadaki I
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):261-70. PubMed ID: 15856232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
    Bittman R; Byun HS; Reddy KC; Samadder P; Arthur G
    J Med Chem; 1997 Apr; 40(9):1391-5. PubMed ID: 9135036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.